The MHRA has approved donidalorsen for long-term prevention of hereditary angioedema, a rare disorder causing potentially life-threatening swelling.

Topline data from CHAPTER-3, a pivotal Phase 3 study of deucrictibant XR for the prophylaxis of HAE attacks, expected in 3Q2026Timeline for ...

As with most rare diseases, the market for hereditary angioedema drugs is small. It’s also relatively crowded, served by several well-established products and two new therapies approved earlier this ...

Data show many patients discontinue or switch treatment within the first year ...

The shares described above were offered by Pharvaris pursuant to an effective shelf registration statement previously filed with the U.S. Securities and Exchange Commission (the “SEC”). The offering ...

Treatment of angioedema is determined by the underlying causative mechanism and the severity of symptoms. Angioedema can be life-threatening, depending on the anatomical location; swelling of the ...

Angioedema is deep swelling that occurs when fluid builds up under your skin or mucus membranes. It may affect your face, throat, gastrointestinal tract, or other parts of your body. Angioedema may ...

Angioedema is basically swelling of the deeper layers of the skin. This is due to accumulation of fluids caused by an allergic reaction. Pathogenesis of the types of angioedema has been studied ...

Angioedema is deep tissue swelling that may occur due to various health conditions. Treating angioedema swelling depends on the cause. Angioedema may be acute or chronic, and acute symptoms may last ...

This article reviews the progress made during the past decade in elucidating the pathophysiological mechanisms of hereditary angioedema and the subsequent development of targeted treatments for the ...